We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Germany Suspends 80 Generic Drugs Over Poor Bioequivalence Trials
Germany Suspends 80 Generic Drugs Over Poor Bioequivalence Trials
German regulators have published a list of 80 generic medicines whose approvals were yanked after EU authorities expressed concerns with contract research organization GVK Biosciences.